Development
Cresco Labs Inc.
CL
CNSX
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -1.02% | -3.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.02% | -3.46% | |||
| Cost of Revenue | -20.28% | -12.83% | |||
| Gross Profit | 19.72% | 9.18% | |||
| SG&A Expenses | -10.44% | -7.45% | |||
| Depreciation & Amortization | 67.92% | 36.75% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.42% | -9.67% | |||
| Operating Income | 24.79% | 102.19% | |||
| Income Before Tax | 110.75% | -303.68% | |||
| Income Tax Expenses | 238.36% | -141.23% | |||
| Earnings from Continuing Operations | 104.29% | -161.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -4.98% | -130.70% | |||
| Net Income | 102.28% | -216.34% | |||
| EBIT | 24.79% | 102.19% | |||
| EBITDA | 27.93% | 43.25% | |||
| EPS Basic | 102.28% | -193.99% | |||
| Normalized Basic EPS | 25.38% | 132.14% | |||
| EPS Diluted | 102.28% | -193.99% | |||
| Normalized Diluted EPS | 25.38% | 132.14% | |||
| Average Basic Shares Outstanding | 0.49% | 7.60% | |||
| Average Diluted Shares Outstanding | 0.49% | 7.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||